Keyphrases
Hepatitis C Virus
66%
Hepatic Stellate Cells
66%
Advance Directives
66%
Advance Care Planning
66%
Decompensated Cirrhosis
66%
C-X-C Chemokine Receptor Type 4 (CXCR4)
47%
Stellate Cell Activation
38%
COVID-19
33%
Post-liver Transplantation
33%
Older Adults
33%
Serious Adverse Events
33%
Sofosbuvir
33%
Liver Function Tests
33%
Cell Contraction
33%
Hepatic Decompensation
33%
Calcium-independent
33%
Chemokine Ligand 12 (CXCL12)
33%
Chronic Hepatitis C
33%
Aged Liver
33%
Kinetic Patterns
33%
Liver Transplant Recipients
33%
Elevated Liver Enzymes
33%
Quality Improvement Study
33%
COVID-19 Related
33%
Cell Behavior
33%
Liver Biopsy
33%
Stromal Cell-derived factor-1 (SDF-1)
33%
Independent Pathway
33%
Antiretroviral
33%
Anti-hepatitis C Virus
33%
Direct-acting Antivirals
33%
Hepatotoxicity
33%
Co-infected Patients
33%
Environmental Factors
33%
Metabolic-associated Fatty Liver Disease (MAFLD)
33%
Steatohepatitis
33%
Significant Fibrosis
33%
Liver Injury
27%
Liver
25%
Vibration-controlled Transient Elastography
23%
AIDS/HIV
22%
Antiretroviral Therapy
22%
Risk Factors
21%
Blood Flow
21%
Stellate Cells
20%
Chronic Liver Disease
20%
Goals of Care Conversations
20%
Fibrosis
17%
Herbal
16%
Comorbidity
16%
Medicine and Dentistry
Decompensated Liver Cirrhosis
100%
Advance Care Planning
66%
Hepatic Stellate Cell
66%
Advance Directive
61%
Stellate Cell
50%
Cell Activation
38%
Liver Transplantation
38%
Fibrosis
37%
Adverse Event
33%
Stromal Cell Derived Factor 1
33%
Sofosbuvir
33%
Outpatient
33%
Quality Improvement
33%
Liver Biopsy
33%
Hepatitis C Virus
33%
Isotopes of Calcium
33%
Metabolic Dysfunction-Associated Steatotic Liver Disease
33%
Steatohepatitis
33%
Environmental Factor
33%
Liver Disease
25%
Blood Flow
22%
Transient Elastography
20%
Liver Fibrosis
19%
Chemokine Receptor CXCR4
18%
Hepatitis C
17%
Serositis
16%
Cellular Senescence
16%
Liver Blood Flow
16%
Liver Function
16%
Medical History
16%
Cell Proliferation
16%
Immune Response
16%
Prescription Medication
16%
Phagocytosis
16%
Oxidative Stress
16%
Prevalence
16%
Portal Hypertension
16%
Comorbidity
16%
Receptor
13%
Rho Kinase
11%
Myosin Light Chain
11%
Chronic Liver Disease
11%
Cumulative Incidence
9%
Liver Graft
9%
Anemia
9%
Transplantation
9%
Logistic Regression Analysis
8%
Fibrogenesis
8%
Mitogen Activated Protein Kinase 3
8%
Electronic Health Record
8%
